user

ASO Visual Abstract: Esophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis

被引：0
|
作者：
Kamarajah, Sivesh K. [1 ,2 ]
Phillips, Alexander W. [3 ,4 ]
Griffiths, Ewen A. [1 ,2 ]
Ferri, Lorenzo [5 ]
Hofstetter, Wayne L. [6 ]
Markar, Sheraz R. [7 ,8 ]
机构：
[1] Univ Hosp Birmingham NHS Trust, Queen Elizabeth Hosp Birmingham, Dept Upper Gastrointestinal Surg, Birmingham, W Midlands, England
[2] Univ Birmingham, Coll Med & Dent Sci, Inst Canc & Genom Sci, Birmingham, W Midlands, England
[3] Newcastle Univ Trust Hosp, Royal Victoria Infirm, Northern Oesophagogastr Unit, Newcastle Upon Tyne, Tyne & Wear, England
[4] Newcastle Univ, Sch Med Educ, Newcastle Upon Tyne, Tyne & Wear, England
[5] McGill Univ, Hlth Ctr, Dept Surg, Div Thorac & Upper Gastrointestinal Surg, Montreal, PQ, Canada
[6] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA
[7] Imperial Coll London, Dept Surg & Canc, London, England
[8] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / SUPPL 3期
关键词：
D O I：
10.1245/s10434-021-10390-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：517 / 518
页数：2
相关论文
共 46 条
  • [21] The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II
    Jessica M. Leers
    Laura Knepper
    Arjen van der Veen
    Wolfgang Schröder
    Hans Fuchs
    Petra Schiller
    Martin Hellmich
    Ulrike Zettelmeyer
    Lodewijk A. A. Brosens
    Alexander Quaas
    Jelle P. Ruurda
    Richard van Hillegersberg
    Christiane J. Bruns
    BMC Cancer, 20
  • [22] The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II
    Leers, Jessica M.
    Knepper, Laura
    van der Veen, Arjen
    Schroeder, Wolfgang
    Fuchs, Hans
    Schiller, Petra
    Hellmich, Martin
    Zettelmeyer, Ulrike
    Brosens, Lodewijk A. A.
    Quaas, Alexander
    Ruurda, Jelle P.
    van Hillegersberg, Richard
    Bruns, Christiane J.
    BMC CANCER, 2020, 20 (01)
  • [23] What is the Optimal Multimodality Approach to Siewert II/III Gastroesophageal Junction Adenocarcinoma? A Population-based Analysis
    Harris, J.
    Huang, B.
    McGrath, P. C.
    McKenzie, S. P.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S166 - S166
  • [24] ASO Visual Abstract: The Effect of Neoadjuvant Therapy on Esophagectomy for cT2N0M0 Esophageal Adenocarcinoma
    Rodriguez-Quintero, Jorge Humberto
    Kamel, Mohamed K.
    Jindani, Rajika
    Elbahrawy, Mostafa
    Vimolratana, Marc
    Chudgar, Neel
    Stiles, Brendon
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (03) : 1595 - 1596
  • [25] The safety of esophagojejunostomy via a transorally inserted-anvil method vs extracorporeal anastomosis using a circular stapler during total gastrectomy for Siewert type 2 adenocarcinoma of the esophagogastric junction
    Chen, Xin-Hua
    Hu, Yan-Feng
    Luo, Jun
    Chen, Yue-Hong
    Liu, Hao
    Lin, Tian
    Chen, Hao
    Li, Guo-Xin
    Yu, Jiang
    GASTROENTEROLOGY REPORT, 2020, 8 (03): : 242 - 251
  • [26] Feasibility Analysis of Involved-Field Irradiation in Patients With Locally Advanced Adenocarcinoma of the Gastroesophageal Junction in Siewert's Type 2 and 3 Undergoing Preoperative Concurrent Chemoradiation Therapy
    Wang, J.
    Zhao, Q.
    Huang, X.
    Jing, S.
    Wang, Y.
    Cao, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E196 - E196
  • [27] ASO Visual Abstract: Use and Costs of Sentinel Lymph Node Biopsy in Nonulcerated T1b Melanoma: Analysis of a Population-Based Registry
    Joshua N. Herb
    David W. Ollila
    Karyn B. Stitzenberg
    Michael O. Meyers
    Annals of Surgical Oncology, 2021, 28 : 3479 - 3479
  • [28] Pembrolizumab (Pembro) or placebo (Pbo) plus chemotherapy (Chemo) for advanced HER2-negative gastric/gastroesophageal junction (G/GEJ) adenocarcinoma (KEYNOTE-859): Asia subgroup analysis
    Oh, D-Y.
    Bai, Y.
    Ryu, M. H.
    Lee, J.
    Li, J.
    Luo, S.
    Pan, H.
    Qu, Y.
    Lu, J.
    Yang, L.
    Yasui, H.
    Yabusaki, H.
    Yen, C. J.
    Chan, W. W. L.
    Yamaguchi, K.
    Yeh, K-H.
    Yin, L.
    Bordia, S.
    Bhagia, P.
    Rha, S. Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S1526 - S1526
  • [29] Pembrolizumab or placebo plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: An updated analysis of KEYNOTE-859 for patients enrolled in Asia.
    Yen, Chia Jui
    Oh, Do-Youn
    Bai, Yuxian
    Ryu, Min-Hee
    Lee, Jeeyun
    Li, Jin
    Yang, Lin
    Yasui, Hisateru
    Yabusaki, Hiroshi
    Lam, Ka On
    Yamaguchi, Kensei
    Yeh, Kun-Huei
    Yin, Lina
    Leconte, Pierre
    Bhagia, Pooja
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 464 - 464
  • [30] HER2-overexpression/amplification and survival in patients with resectable esophageal/gastroesophageal junction adenocarcinoma (E/GEJ-AC) treated with neoadjuvant carboplatin/paclitaxel-based chemoradiation.
    Feng, Yening
    Condell, Sanhueza Cristobal Tomas
    Hallemeier, Christopher Leigh
    Blackmon, Shanda H.
    Hubbard, Joleen M.
    Halfdanarson, Thorvardur Ragnar
    Hobday, Timothy J.
    Cassivi, Stephen D.
    Shen, Robert
    Neben-Wittich, Michelle A.
    Nichols, Francis C.
    Merrell, Kenneth
    Blanco, Ellen W.
    McWilliams, Robert R.
    Alberts, Steven R.
    Pitot, Henry C.
    Jatoi, Aminah
    Haddock, Michael G.
    Wigle, Dennis A.
    Yoon, Harry H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
12345